On June 26, 2025, the U.S. Supreme Court issued its decision in Medina v. Planned Parenthood South Atlantic. The ruling determined that Medicaid enrollees cannot sue in federal court to enforce their right to choose any qualified family planning provider—a right that, until now, included providers like Planned Parenthood.
This decision is part of a decades-long effort to exclude Planned Parenthood from Medicaid and other publicly funded programs. Medicaid plays a crucial role in reproductive health, covering 44% of low-income women aged 18–49 in 2023. It funds contraception, cancer screenings, STI testing and treatment, and other essential services.
Our new study shows the scale and scope of what is likely to come if the budget bill blocks Planned Parenthood from participating in Medicaid.
According to Planned Parenthood’s internal data from all 587 affiliated health centers, there were over 1.5 million visits for Medicaid-covered non-abortion services in 2024.
Allowing the exclusion of Planned Parenthood in Medicaid will likely result in less timely, worse, or even nonexistent access to family planning care for many women who do not have better alternatives.
Texas, which began excluding Planned Parenthood from Medicaid in 2013, can tell the tale of what may happen nationally.
• Former Planned Parenthood Medicaid patients may have a harder time accessing highly effective contraception; births covered by Medicaid could also increase.
• Other providers may not be able to fill the gaps in care after Planned Parenthood is excluded.
• Difficulties accessing care may be particularly pronounced in medically underserved communities.
• Concurrent cuts to Title X federal family planning and other changes to Medicaid eligibility will further fray the family planning safety net in the US.
